Gelderblom, H. C., Lewis, D. J. M., Streatfield, C., Hassanin, H., Hare, J., Welsh, S., … Priddy, F. (2018). A Phase 1 Trial of AAV1 Vectored Immunoprophylaxis for HIV. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 34, pp. 183–183). Madrid, SPAIN: MARY ANN LIEBERT, INC.

Gelderblom, Huub C., David J. M. Lewis, Claire Streatfield, Hana Hassanin, Jonathan Hare, Sabrina Welsh, Daryl Bendel, et al. “A Phase 1 Trial of AAV1 Vectored Immunoprophylaxis for HIV.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 34:183–183. MARY ANN LIEBERT, INC, 2018.

Gelderblom HC, Lewis DJM, Streatfield C, Hassanin H, Hare J, Welsh S, et al. A Phase 1 Trial of AAV1 Vectored Immunoprophylaxis for HIV. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 183–183.

Gelderblom, Huub C., et al. “A Phase 1 Trial of AAV1 Vectored Immunoprophylaxis for HIV.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 34, MARY ANN LIEBERT, INC, 2018, pp. 183–183.

Gelderblom HC, Lewis DJM, Streatfield C, Hassanin H, Hare J, Welsh S, Bendel D, Johnson P, Sayeed E, Ackland J, Wrin T, Montefiori D, Pensiero M, Gilmour J, Priddy F. A Phase 1 Trial of AAV1 Vectored Immunoprophylaxis for HIV. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT, INC; 2018. p. 183–183.